Pre-launch evidence toolkit for PD-L1 checkpoint inhibitor: MSL deck, payer summary, FAQ, and KOL guide for 4 oncology markets
Six weeks to launch, and three teams with different material needs
A PD-L1 inhibitor approval was confirmed six weeks before the planned launch date across four oncology markets. The Medical Affairs, Market Access, and Brand teams all needed materials — but each team's requirements were different, and the materials had not been coordinated from a shared core document.
MSLs needed a scientifically detailed slide deck with full clinical trial data. Payers needed a concise evidence summary focused on comparative effectiveness and budget impact. KOLs needed an engagement guide covering the scientific landscape, the brand's data position, and anticipated questions from other experts. Internal teams needed a FAQ covering every likely question from any stakeholder.
Without a shared evidence architecture, each team risked developing materials that contradicted each other — creating different versions of the clinical story for different audiences. With only six weeks to launch, there was no time to manage four parallel workstreams independently.
Launch success depends on one coherent scientific narrative expressed through multiple formats. The mistake is to build the formats before the narrative — or to let each function build its own.
What we did
Measurable impact
The complete toolkit — MSL deck, payer summary, KOL guide, and FAQ — was delivered for all 4 markets six weeks before the planned launch date. All materials were aligned to the shared core evidence architecture. The Medical Director of one market commented that it was the most coherent pre-launch package the team had received for any product in the previous five years. Launch meetings proceeded with consistent messaging across all stakeholder types.
From the field:
evidence & practice
AI-powered.
Expert-validated.
We built AI workflows into our daily practice — not as a marketing claim, but as the infrastructure that lets our medical experts deliver faster without cutting corners.
Tell us what you’re working on — we’ll show you relevant cases and suggest the fastest path forward.